Soligenix to Present at The Microcap Conference
PRINCETON, N.J., Jan. 25, 2024 /PRNewswire/ — Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that the Company will deliver a corporate presentation at The Microcap Conference. The conference will be held January 30 and 31, and February 1, 2024 at Caesars Atlantic City Hotel & Casino in Atlantic City, N.J. For more information about The Microcap Conference, please refer to the conference website at https://themicrocapconference.com.
Related news for (SNGX)
- Don’t Miss Out: MoBot’s Latest Stock Updates 10/07/25 12:00 PM
- Soligenix Achieves Important Safety Milestone in its Confirmatory Phase 3 Clinical Trial of HyBryte™ for the Treatment of Cutaneous T-Cell Lymphoma
- 24/7 Market News Snapshot 07 October, 2025 – Soligenix, Inc. Common Stock (NASDAQ:SNGX)
- Soligenix Announces Expansion of European Medical Advisory Board for Cutaneous T-Cell Lymphoma
- Soligenix Announces Closing of $7.5 Million Public Offering